Glenmark Life Sciences Limited IPO OPENS TODAY: Check issue size, price band, lot size, minimum and maximum investment, important dates and more
Glenmark Life Sciences Limited IPO Date: The issue comprises a fresh issue of equity shares worth Rs 1,060 crore and an offer for sale by existing shareholders worth Rs 453 crore
Glenmark Life Sciences Limited IPO opened for public subscription today (Tuesday, July 27, 2021). The IPO that comes in the price range of Rs 695 to Rs 720 will conclude on July 29, 2021. Minimum investment required for Glenmark Life Sciences Limited IPO is Rs 13,900 and it comprises a lot size of 20. Glenmark Life Sciences Limited IPO issue size has been fixed at Rs 1513.60 crore.
See Zee Business Live TV Streaming Below:
Though Glenmark Life Sciences Limited IPO will open for subscription on genral demat account and other platforms from Tuesday, there are certain apps and platforms that had enabled preopen subscription in advance. A pre-apply feature enables investors to invest in an IPO 3 to 4 days in advance.
Glenmark Life Sciences Limited IPO Key Dates
Glenmark Life Sciences Limited IPO last date : July 29, 2021
Glenmark Life Sciences Limited IPO allotment finalisation: August 3, 2021
Glenmark Life Sciences Limited IPO refund Initiation: August 4, 2021
Glenmark Life Sciences Limited IPO listing date: August 6, 2021
Glenmark Life Sciences Limited IPO IMPORTANT Details
Glenmark Life Sciences Limited IPO Issue size: A fresh issue of equity shares worth Rs 1,060 crore and an offer for sale by existing shareholders worth Rs 453 crore
Glenmark Life Sciences Limited IPO Price Band: Rs 695 to Rs 720 per equity share.
Glenmark Life Sciences Limited IPO lot size: 20 equity shares and in multiples of 20 equity shares thereafter.
Glenmark Life Sciences Limited IPO Price purchase limit on UPI: Rs 2 lakh per transaction
Glenmark Life Sciences Limited IPO Price Band size Issue type: Book Building Process.
Glenmark Life Sciences Limited IPO offer allocation: 15 per cent for Non-Institutional Bidders and 35 per cent Retail Individual Investors.
Glenmark Life Sciences Limited is a subsidiary of Glenmark Pharmaceuticals Limited. The parent company is a leading developer and manufacturer of select high-value , non-commoditized active pharmaceutical ingredients (APIs).
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.